Category: Life sciences

6 Ways to Improve Your Life Sciences Company’s Sarbanes-Oxley Compliance This Year

At every point along the business lifecycle, life sciences companies are on the fast track. They’re chasing after a new discovery or a new method of treatment, or actively anticipating approval to commercialize their lat…

See More

Rethinking revenue and realizing opportunities in the new rules

It’s game time. Deals your company is making now could be affected by the new revenue recognition standard, and the effective date will be here before you know it. This is why it is so important for finance organizations…

See More

Conquer complexity: Get briefed on the latest accounting updates

In the accounting world, the rules are ever changing. Large in scope and long awaited, the new rule for recognizing revenue continues to get clarifications in the months leading up to its effective date. The new leasing st…

See More

Hot deals, talent wars and ‘winning’ entrepreneurs: Just another day in Menlo Park

Optimism in the air—that was the first thing you would have noticed at an EY Entrepreneur of the Year® reception at the Rosewood Sand Hill last week. As I walked through the hotel’s reception area, I couldn’t miss …

See More

The 4 stages of the business lifecycle and how to recognize what you need next

Many companies tend to follow similar patterns as they adapt and change over time. The trajectory is known as the business lifecycle, and we’ve identified four particular stages that companies typically move through from…

See More

Revenue recognition: Are you in denial?

After more than a decade in the making, the FASB and the IASB finally issued new revenue recognition rules. Now if the boards needed that kind of a runway, how hard will it be for companies to implement? This is what manag…

See More

How the new revenue recognition standard may affect your company

We’ve been hearing about it for years. Finally, the result of the joint project between the FASB and the IASB to update and consolidate accounting standards for revenue recognition into one global standard is just about …

See More

Life Sciences Roundtable tackles challenges along product development-to-launch trajectory

RoseRyan has been supporting clients in the life sciences industry for nearly two decades. In addition to providing assistance on many aspects of accounting, we host a Life Sciences Roundtable twice a year. The event bring…

See More

RoseRyan nurtures life sciences companies with QB3 Accelerator program

We’re pleased to announce that we are a partner of the brand-new QB3 Accelerator program, created by the California Institute for Quantitative Biosciences (QB3) to help life sciences companies become operationally effici…

See More

The view from Mission Bay: the future of biotech looks pretty bright

I was fortunate to attend “Winning Strategies in Life Sciences: Pursuing Success in Today’s Changing Environment,” an all-day conference held October 5 at the University of California, San Francisco’s beautiful new…

See More